Paediatric Consumer Health in Estonia

Paediatric Consumer Health in Estonia

In 2024, safety remains a top priority for Estonian parents when selecting healthcare products for their children, with a clear preference for trusted, well-established brands. Brands such as Nurofen and Panadol continue to dominate the market for fever reducers, as they are perceived as reliable and effective solutions for managing common childhood ailments. Similarly, Brontex has become a preferred choice for paediatric cough syrups, specifically formulated to address children’s needs. Beyond...

Euromonitor International's Paediatric Consumer Health in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.